The University of Chicago Header Logo

Connection

S. Murray Sherman to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications S. Murray Sherman has written about Cost-Benefit Analysis.
S. Murray Sherman
Connection Strength
0.023
Cost-Benefit Analysis
  1. Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am J Gastroenterol. 2013 Mar; 108(3):410-5.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.